Dillon & Associates Inc Novartis Ag Transaction History

Dillon & Associates Inc

$673 Million
Q1 2025

A detailed history of Dillon & Associates Inc transactions in Novartis Ag stock. As of the latest transaction made, Dillon & Associates Inc holds 3,061 shares of NVS stock, worth $342,434. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,061

Previous 3,134 2.33%

Holding current value

$342,434

Previous $304,000 11.84%

% of portfolio

0.05%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$97.14 - $115.57 $7,091 - $8,436	-73 Reduced 2.33%	3,061 $340,000
Q4 2024 Feb 11, 2025	SELL	$96.78 - $117.18 $9,678 - $11,718	-100 Reduced 3.09%	3,134 $304,000
Q3 2024 Nov 05, 2024	SELL	$106.13 - $120.89 $192,625 - $219,415	-1,815 Reduced 35.95%	3,234 $372,000
Q2 2024 Aug 06, 2024	SELL	$92.57 - $107.37 $25,364 - $29,419	-274 Reduced 5.15%	5,049 $535,000
Q1 2024 Apr 30, 2024	SELL	$95.27 - $108.47 $19,054 - $21,694	-200 Reduced 3.62%	5,323 $516,000
Q4 2023 Feb 08, 2024	SELL	$92.27 - $101.54 $37,092 - $40,819	-402 Reduced 6.78%	5,523 $558,000
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $47,270 - $52,459	-499 Reduced 7.77%	5,925 $604,000
Q2 2023 Aug 08, 2023	SELL	$92.52 - $104.91 $7,401 - $8,392	-80 Reduced 1.23%	6,424 $649,000
Q1 2023 May 02, 2023	SELL	$80.03 - $92.81 $155,658 - $180,515	-1,945 Reduced 23.02%	6,504 $598,000
Q1 2023 May 01, 2023	BUY	$80.03 - $92.81 $6,402 - $7,424	80 Added 0.96%	8,449 $777,000
Q4 2022 Feb 06, 2023	SELL	$75.55 - $92.52 $6,044 - $7,401	-80 Reduced 0.95%	8,369 $762,000
Q1 2021 May 10, 2021	SELL	$83.5 - $98.47 $4,175 - $4,923	-50 Reduced 0.59%	8,449 $718,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $14,833 - $17,941	-190 Reduced 2.19%	8,499 $799,000
Q1 2020 May 07, 2020	SELL	$70.67 - $99.01 $17,667 - $24,752	-250 Reduced 2.8%	8,689 $712,000
Q4 2019 Feb 03, 2020	BUY	$84.35 - $95.37 $16,026 - $18,120	190 Added 2.17%	8,939 $849,000
Q3 2019 Oct 25, 2019	SELL	$85.54 - $94.26 $1,112 - $1,225	-13 Reduced 0.15%	8,749 $761,000
Q2 2019 Jul 22, 2019	BUY	$75.4 - $92.8 $1,885 - $2,320	25 Added 0.29%	8,762 $797,000
Q1 2019 May 07, 2019	SELL	$75.32 - $86.15 $26,361 - $30,152	-350 Reduced 3.85%	8,737 $839,000
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $1,673 - $1,935	-25 Reduced 0.27%	9,087 $781,000
Q2 2018 Aug 08, 2018	SELL	$64.91 - $73.36 $87,628 - $99,036	-1,350 Reduced 12.9%	9,112 $693,000
Q1 2018 May 08, 2018	SELL	$70.39 - $84.15 $17,597 - $21,037	-250 Reduced 2.33%	10,462 $847,000
Q3 2017 Nov 13, 2017	SELL	$74.14 - $77.27 $1,853 - $1,931	-25 Reduced 0.23%	10,712 $921,000
Q2 2017 Aug 09, 2017	BUY	N/A	10,737	10,737 $891,000

Others Institutions Holding NVS

# of Institutions

1,524

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $241B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dillon & Associates Inc with notifications on news.

Account

Dillon & Associates Inc Novartis Ag Transaction History